Clinical significance of IL-18 gene over-expression in AML
- 1 October 2002
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 26 (10) , 887-892
- https://doi.org/10.1016/s0145-2126(02)00025-5
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Regulation of interferon-γ production by IL-12 and IL-18Current Opinion in Immunology, 1998
- Characterization of anti-human interleukin-18 (IL-18)/interferon-γ-inducing factor (IGIF) monoclonal antibodies and their application in the measurement of human IL-18 by ELISAJournal of Immunological Methods, 1997
- Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2.Journal of Clinical Investigation, 1997
- Activation of Interferon-γ Inducing Factor Mediated by Interleukin-1β Converting EnzymeScience, 1997
- Cloning of a new cytokine that induces IFN-γ production by T cellsNature, 1995
- Enhancement of J6-1 human leukemic cell proliferation by cell—Cell contact: Role of an M-CSF-like membrane-associated growth factor MAF-J6-1Leukemia Research, 1994
- Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem‐cell glycoprotein CD34 (My 10)British Journal of Haematology, 1990
- Tumor necrosis factor alpha stimulates the growth of the clonogenic cells of acute myeloblastic leukemia in synergy with granulocyte/macrophage colony-stimulating factor.The Journal of Experimental Medicine, 1989
- Interleukin 1 as an autocrine growth factor for acute myeloid leukemia cells.Proceedings of the National Academy of Sciences, 1989
- Proposed Revised Criteria for the Classification of Acute Myeloid LeukemiaAnnals of Internal Medicine, 1985